| 000 | 01621 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517190126.0 | ||
| 264 | 0 | _c20180705 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1872-8332 | ||
| 024 | 7 |
_a10.1016/j.lungcan.2017.08.017 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYu, Helena A | |
| 245 | 0 | 0 |
_aPhase 2 study of intermittent pulse dacomitinib in patients with advanced non-small cell lung cancers. _h[electronic resource] |
| 260 |
_bLung cancer (Amsterdam, Netherlands) _c10 2017 |
||
| 300 |
_a195-199 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aPulse Therapy, Drug |
| 650 | 0 | 4 |
_aQuinazolinones _xadministration & dosage |
| 700 | 1 | _aAhn, Myung-Ju | |
| 700 | 1 | _aCho, Byoung Chul | |
| 700 | 1 | _aGerber, David E | |
| 700 | 1 | _aNatale, Ronald B | |
| 700 | 1 | _aSocinski, Mark A | |
| 700 | 1 | _aGiri, Nagdeep | |
| 700 | 1 | _aQuinn, Susan | |
| 700 | 1 | _aSbar, Eric | |
| 700 | 1 | _aZhang, Hui | |
| 700 | 1 | _aGiaccone, Giuseppe | |
| 773 | 0 |
_tLung cancer (Amsterdam, Netherlands) _gvol. 112 _gp. 195-199 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.lungcan.2017.08.017 _zAvailable from publisher's website |
| 999 |
_c27840977 _d27840977 |
||